BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5433696)

  • 1. A specific method for purification of the second component of guinea pig complement and a chemical evaluation of the one-hit theory.
    Mayer MM; Miller JA; Shin HS
    J Immunol; 1970 Aug; 105(2):327-41. PubMed ID: 5433696
    [No Abstract]   [Full Text] [Related]  

  • 2. Canine hemolytic complement: optimal conditions for its titration.
    Barta O; Barta V
    Am J Vet Res; 1973 May; 34(5):653-7. PubMed ID: 4634064
    [No Abstract]   [Full Text] [Related]  

  • 3. The purification and reactivity of the first component of complement from guinea pig, human and canine sera.
    Tamura N; Nelson RA
    J Immunol; 1968 Dec; 101(6):1333-45. PubMed ID: 4972623
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the third component (C'3) of guinea pig complement. I. Purification and characterization.
    Yonematsu K; Inoue K
    Biken J; 1968 Sep; 11(3):169-80. PubMed ID: 4976235
    [No Abstract]   [Full Text] [Related]  

  • 5. C2--the second component of guinea pig complement: purification and physico-chemical characterization.
    Wagner H; Röllinghoff M
    Immunochemistry; 1970 Dec; 7(12):977-87. PubMed ID: 4100761
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification of the first component of complement by zonal ultracentrifugation.
    Colten HR; Bond HE; Borsos T; Rapp HJ
    J Immunol; 1969 Oct; 103(4):862-5. PubMed ID: 4981689
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular analysis of the reaction of C9 with EAC1-8: reaction of C9 with EAC1-8.
    Kitamura H; Inai S
    J Immunol; 1974 Dec; 113(6):1992-2003. PubMed ID: 4214868
    [No Abstract]   [Full Text] [Related]  

  • 8. [A method for the specific purification of the first complement component C1].
    Wunderlich R; Ringelmann R
    Med Microbiol Immunol; 1972; 157(2):120-31. PubMed ID: 5063560
    [No Abstract]   [Full Text] [Related]  

  • 9. Mode of action of human C9: adsorption of multiple C9 molecules to cell-bound C8.
    Kolb WP; Müller-Eberhard HJ
    J Immunol; 1974 Aug; 113(2):479-88. PubMed ID: 4858623
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrophoresis of guinea-pig complement components (C3, C5, C6, C7, C8 and C9) on polyacrylamide gel.
    Okada H; Mayumi M; Mukojima T; Sekine T; Torisu M
    Immunology; 1970 Apr; 18(4):493-500. PubMed ID: 5421032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of the first component of human complement by affinity chromatography on human globulin linked to sepharose.
    Bing DH
    J Immunol; 1971 Nov; 107(5):1243-9. PubMed ID: 4107360
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system.
    Stolfi RL
    J Immunol; 1968 Jan; 100(1):46-54. PubMed ID: 4169697
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparation of antisera monospecifically reactive with the fourth component of guinea pig complement.
    Burkholder PM
    Int Arch Allergy Appl Immunol; 1969; 35(6):552-63. PubMed ID: 4977621
    [No Abstract]   [Full Text] [Related]  

  • 14. A simple method for the isolation of the subcomponents of the first component of complement by affinity chromatography.
    Assimeh SN; Bing DH; Painter RH
    J Immunol; 1974 Jul; 113(1):225-34. PubMed ID: 4857625
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of isoelectric points of guinea pig complement components.
    Mukojima T
    Bull Tokyo Med Dent Univ; 1970 Jun; 17(2):75-88. PubMed ID: 5271548
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible loss of activity of the first component of complement (C'1) as a function of ionic strength.
    Colten HR; Borsos T; Rapp HJ
    J Immunol; 1968 Apr; 100(4):799-807. PubMed ID: 5645221
    [No Abstract]   [Full Text] [Related]  

  • 17. Lysis of human erythrocytes due to activation of the alternate complement pathway by nephritic factor (C3NeF).
    Arroyave CM; Vallota EH; Müller-Eberhard HJ
    J Immunol; 1974 Sep; 113(3):764-8. PubMed ID: 4547248
    [No Abstract]   [Full Text] [Related]  

  • 18. [The C1-inactivator of guinea pig serum: titration, purification and characterization of the inactivator].
    Opferkuch W; Loos M; Ringelmann R
    Z Med Mikrobiol Immunol; 1971; 156(2):194-207. PubMed ID: 4995249
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemolytic assay of bovine serum complement.
    Barta O; Barta V
    J Immunol Methods; 1972 Aug; 1(4):363-74. PubMed ID: 4218251
    [No Abstract]   [Full Text] [Related]  

  • 20. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
    Ballow M; Cochrane CG
    J Immunol; 1969 Nov; 103(5):944-52. PubMed ID: 4981797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.